Pharsight

Acanya patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5733886 BAUSCH Compositions of clindamycin and benzoyl peroxide for acne treatment
Mar, 2015

(9 years ago)

US8895070 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(4 years from now)

US10220049 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(4 years from now)

US9078870 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(4 years from now)

US10624918 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(4 years from now)

US8663699 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Jun, 2029

(4 years from now)

US8288434 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Aug, 2029

(5 years from now)

Acanya is owned by Bausch.

Acanya contains Benzoyl Peroxide; Clindamycin Phosphate.

Acanya has a total of 7 drug patents out of which 1 drug patent has expired.

Expired drug patents of Acanya are:

  • US5733886

Acanya was authorised for market use on 23 October, 2008.

Acanya is available in gel;topical dosage forms.

Acanya can be used as topical treatment of acne vulgaris in patients 12 years or older, treatment of acne.

The generics of Acanya are possible to be released after 05 August, 2029.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE ingredient

Market Authorisation Date: 23 October, 2008

Treatment: Treatment of acne; Topical treatment of acne vulgaris in patients 12 years or older

Dosage: GEL;TOPICAL

How can I launch a generic of ACANYA before it's drug patent expiration?
More Information on Dosage

ACANYA family patents

Family Patents